A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapySEGAWA, Y; AOGI, K; INOUE, K et al.Annals of oncology. 2009, Vol 20, Num 11, pp 1874-1880, issn 0923-7534, 7 p.Article

A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapyMAEMONDO, M; MASUDA, N; SEKINE, I et al.Annals of oncology. 2009, Vol 20, Num 11, pp 1860-1866, issn 0923-7534, 7 p.Article